Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The twenty-first century has come with a new era in vaccinology, in which recombinant genetic technology has contributed to setting an unprecedented fast pace in vaccine development, clearly demonstrated during the recent COVID-19 pandemic.

Original publication

DOI

10.1038/s41541-020-0188-3

Type

Journal article

Journal

NPJ vaccines

Publication Date

01/2020

Volume

5

Addresses

The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.